Aquest dimarts 11 d’octubre s’ha celebrat en una jornada online el llan\u00e7ament del projecte COST Action HAPLO-iPS. Durant la jornada s’han nomenat diferents c\u00e0rrecs directius i s’han assignat els coordinadors dels set grups de treball pr\u00e8viament definits.<\/p>\n
El projecte COST Action HAPLO-iPS, liderat per la Dra. Anna Veiga, cap de grup de l’IDIBELL i del P-CMRC i directora del Banc de L\u00ednies Cel\u00b7lulars de Barcelona, crear\u00e0 una xarxa de col\u00b7laboraci\u00f3 per a la generaci\u00f3 de c\u00e8l\u00b7lules mare (iPS) homozigotes amb \u00a0haplotips HLA m\u00e9s freq\u00fcents. Aquestes iPSpoden ser utilitzades per la producci\u00f3 de c\u00e8l\u00b7lules per a assaigs cl\u00ednics de ter\u00e0pia cel\u00b7lular compatibles amb un percentatge significatiu de la poblaci\u00f3. En el projecte es desenvolupar\u00e0\u00a0 un sistema de recollida de dades\u00a0 per a aquestes l\u00ednies.<\/p>\n
El repte s’abordar\u00e0 treballant en xarxa amb tots els agents implicats compartint coneixement, estandarditzant la metodologia i desenvolupant un programa de formaci\u00f3\u00a0 per a investigadors.<\/p>\n
Aquesta xarxa inclou tots els grups d’inter\u00e8s rellevants: centres de generaci\u00f3 o bancs d’hiPS, bancs de sang de cord\u00f3 umbilical, centres de producci\u00f3 cel\u00b7lular , experts en immunologia, , experts en control de qualitat, organismes reguladors, ag\u00e8ncies nacionals i experts en bio\u00e8tica.<\/p>\n
HAPLO-iPS tamb\u00e9 promou la participaci\u00f3 d’investigadors procedents de pa\u00efsos amb menys activitat investigadora . Aquests participants tindran acc\u00e9s a centres de recerca d\u2019excel\u00b7l\u00e8ncia, cursos de formaci\u00f3 programes de tutoria per a joves investigadors.<\/p>\n
En conjunt, aquesta proposta ser\u00e0 pionera en nous enfocaments que fomentaran el progr\u00e9s de la generaci\u00f3 d’hiPS haplo-seleccionades \u00a0per l\u2019aplicaci\u00f3 cl\u00ednica\u00a0 en ter\u00e0pia cel\u00b7lular \u00a0en benefici dels pacients.<\/p>\n
<\/p>\n
<\/p>\n
L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" El projecte pret\u00e9n crear una xarxa de col\u00b7laboraci\u00f3 per a la generaci\u00f3 de c\u00e8l\u00b7lules mare de pluripotencia indu\u00efda (iPS) homozigotes per als haplotips HLA m\u00e9s freq\u00fcents.<\/p>\n","protected":false},"author":8,"featured_media":22287,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[349,482,486],"tags":[],"class_list":["post-22286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicina-regenerativa","category-p-de-medicina-regenerativa","category-terapia-amb-cellules-mare-pluripotencials"],"publishpress_future_action":{"enabled":false,"date":"2024-11-29 02:22:59","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=22286"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22286\/revisions"}],"predecessor-version":[{"id":22288,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22286\/revisions\/22288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/22287"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=22286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=22286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=22286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}